A Study to Evaluate the Safety and Pharmacokinetic of Recombinant Human Coagulation Factor VIII ，Fc Fusion Protein for Injection
Clinical trial NCT05251090 · COMPLETED
Trial details
- NCT number
- NCT05251090
- Sponsor
- Hangzhou Gensciences Biopharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-16
- Primary completion
- 2021-11-15
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.